Healthcare -
Biotechnology - NASDAQ - US
$ 0.6658
-6.33 %
$ 195 M
Market Cap
-0.84
P/E
Price Target
Average
688.53%
Revenue Forecast
Estimate
--50.00%
EBIT
Estimate
99.97%
Net Income
Estimate
44.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lyell Immunopharma, Inc.
Wall Street analysts predict an average 1-year price target for LYEL of $5.25 , with forecasts ranging from
a
low of
$1 to a high of $12 .
LYEL Lowest Price Target
Wall Street Target
1 USD
50.20%
LYEL Average Price Target
Wall Street Target
5.25 USD
688.53%
LYEL Highest Price Target
Wall Street Target
12 USD
1702.34%
REVENUE FORECAST
Revenue Forecast Chart LYEL
EBIT FORECAST
EBIT Forecast Chart LYEL
NET INCOME FORECAST
Net Income Chart LYEL